Fluorescent Antibody Technique: Clinical Trials

12 trials of Fluorescent Antibody Technique, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 2 not yet recruiting, 2 terminated, 1 recruiting. 1 Not applicable, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable1Terminated 1
Phase 11Terminated 1

Follow Fluorescent Antibody Technique: new trials by email Literature Review of Fluorescent Antibody Technique trials Research Report on Fluorescent Antibody Technique

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Intratumoral Microbiota and Immune Microenvironment in Prostate Cancer
Validate spatial localization of candidate microbial signals via 16S rRNA ISH, FISH, immunofluorescence, IHC, and spatial omics. - Prostate Cancer Adenocarcinoma
Not yet recruitingAnhui Medical University1002026-10-012026-09-14
Histidine and Immunotherapy Response in Colorectal Cancer
Immunohistochemistry or immunofluorescence, Serum metabolomic analysis or ELISA, Flow cytometry - Colorectal Cancer
Not yet recruitingJing-yuan Fang, MD, Ph. D1502026-05-012026-05-14
Proteinopathies Expression in Skin of Neurodegenerative Disorders
Immunohistochemistry and immunofluorescence - Alzheimer Disease, Frontotemporal Dementia
RecruitingUniversidad Autonoma de San Luis Potosí402023-12-202024-12-16
Influenza Vaccine in Preventing Flu in Patients Who Have Undergone Stem Cell Transplant and in Healthy Volunteers
cytology specimen collection procedure, fluorescent antibody technique, assessment of therapy complications - Brain and Central Nervous System Tumors, Chronic Myeloproliferative Disorders
Not applicableTerminatedCity of Hope Medical Center92008-11-012015-06-08
Retrospective Study Evaluating IGF1R And p95HER2 as Prognostic Factors in Non Small Cell Lung Cancer (NSCLC)
Protein expression by immunohistochemistry and immunofluorescence - Non Small Cell Lung Cancer
CompletedArmando Santoro, MD4542007-11-012022-09-10
S9313A Protein Expression Analysis of Breast Cancer Tissue Microarrays From Clinical Trial SWOG-9313
gene expression analysis, protein expression analysis, fluorescent antibody technique - Breast Cancer
CompletedSWOG Cancer Research Network21002006-07-172019-12-20
Biomarkers in Predicting Response to Tamoxifen and Letrozole in Postmenopausal Women With Primary Breast Cancer Treated on Clinical Trial CAN-NCIC-MA17
microarray analysis, polymerase chain reaction, protein expression analysis - Breast Cancer
UnknownMassachusetts General Hospital9572006-06-012013-07-10
S0424 - Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Diagnosed Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
chromogenic in situ hybridization, gene expression analysis, mutation analysis - Lung Cancer
CompletedSWOG Cancer Research Network9812005-10-012015-10-26
Studying Blood and Tumor Tissue Samples in Women With Invasive Breast Cancer, Ductal or Lobular Carcinoma in Situ, or Benign Breast Disease
gene expression analysis, mutation analysis, proteomic profiling - Breast Cancer
CompletedCity of Hope Medical Center5632005-08-192026-10-20
Study of Proteins in Head and Neck Cancer Cells
Southern blotting, TdT-mediated dUTP nick end labeling assay, gene expression analysis - Head and Neck Cancer
CompletedVanderbilt University Medical Center2005-05-012017-03-14
EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma
EF5, flow cytometry, fluorescent antibody technique - Breast Cancer, Cervical Cancer
Phase 1TerminatedUniversity Health Network, Toronto1999-12-012018-02-22
Detection of Biomarkers in Abnormal Cervical Cells in Women With Abnormal Pap Test Results
Papanicolaou test, cytology specimen collection procedure, fluorescent antibody technique - Cervical Cancer
CompletedNorthwestern University1001999-08-012011-01-31

Conditions studied

Breast Neoplasms (4)  ·  Breast Carcinoma In Situ (2)  ·  Carcinoma, Non-Small-Cell Lung (2)  ·  Head and Neck Neoplasms (2)  ·  Prostatic Neoplasms (2)  ·  Uterine Cervical Neoplasms (2)  ·  Alzheimer Disease (1)  ·  Amyotrophic Lateral Sclerosis (1)  ·  Anemia, Aplastic (1)  ·  Blast Crisis (1)  ·  Burkitt Lymphoma (1)  ·  Carcinoma, Ductal, Breast (1)  ·  Carcinoma, Intraductal, Noninfiltrating (1)  ·  Carcinoma, Lobular (1)  ·  Central Nervous System Neoplasms (1)

Sponsors

City of Hope Medical Center (2)  ·  SWOG Cancer Research Network (2)  ·  Anhui Medical University (1)  ·  Armando Santoro, MD (1)  ·  Jing-yuan Fang, MD, Ph. D (1)  ·  Massachusetts General Hospital (1)  ·  Northwestern University (1)  ·  Universidad Autonoma de San Luis Potosí (1)  ·  University Health Network, Toronto (1)  ·  Vanderbilt University Medical Center (1)

Countries

United States (7)  ·  Canada (1)  ·  China (1)  ·  Italy (1)  ·  Mexico (1)

Top investigators

Anthony Fyles, MD (1)  ·  Aprille Seidel, PhD (1)  ·  Armando Santoro, MD (1)  ·  Christine B. Ambrosone, PhD (1)  ·  David Rimm, MD (1)  ·  Jing-Yuan Fang, M.D. (1)  ·  Kathy S. Albain, MD (1)  ·  Paul E. Goss, MD, PhD (1)  ·  Paul H. Gumerlock, PhD (1)  ·  Phillip Y. Roland, MD (1)  ·  Regina M. Santella, PhD (1)  ·  Robert Hickey, Ph.D. (1)  ·  Wendell G. Yarbrough, MD, FACS (1)

Results publications

PMID 25387460, PMID 28434677, PMID 28912244, PMID 29567829, PMID 30046175, PMID 30497919, PMID 31398337, PMID 32467386, PMID 33766858, PMID 35450835, PMID 38230766, PMID 38572751, PMID 39036382

NIH funding

P30CA033572 (2), P30CA068485 (1), U10CA032102 (1)